Inside the research

Merit Medical Systems, Inc.

MMSI Research profile · latest available data

Price overview

$87.50

▲ +0.20 (+0.2%)

52w hi$93.18
52w lo$60.31
Vol354.00K
As of25 Sep 2026

The Verdict

Hold

Our score +0.37

Short+0.25
Medium+0.48
Long+0.39

computed 2026-09-27

Key fundamentals

Merit Medical Systems, Inc.

Healthcare · Medical Instruments & Supplies

Market cap$5.22B
Enterprise value$5.60B
Trailing P/E36.01x
Forward P/E18.97x
EV / EBITDA16.51x
P / S (ttm)3.31x
Profit margin9.2%
Return on equity9.2%
Revenue growth+9.5%
Earnings growth+20.4%
Debt / equity48.82

Layer Breakdown

LayerRawContribution
Fundamental+0.26
Sector+0.08
Technical+0.21
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

United States · www.merit.com

Risk Metrics

Beta vs SPX0.77
Corr SPX0.42
Annual vol29.2%
Annual ret-2.1%
Sharpe-0.07
Max DD-45.3%

Window: 504 trading days (504 obs)

Material Events

DateEvent8-K
2026-07-30Earnings Release, Reg FD Disclosure…read
2026-05-19Officer / Director Change, Bylaws Amendment…read
2026-04-30Earnings Release, Reg FD Disclosure…read
2026-04-13Reg FD Disclosure, Exhibitsread
2026-04-01Reg FD Disclosure, Exhibitsread
2026-02-24Earnings Release, Reg FD Disclosure…read
2026-01-08Earnings Release, Officer / Director Change…read
2025-11-13Reg FD Disclosure, Exhibitsread
2025-11-03Reg FD Disclosure, Exhibitsread
2025-10-30Earnings Release, Reg FD Disclosure…read
2025-10-17Reg FD Disclosure, Exhibitsread
2025-10-10Officer / Director Changeread

Insider Trades

DateInsiderRoleActionSharesValue
2026-08-04Peterson Neil W.Officer, CHIEF OPERATING Sell21.45K$1.82M
2026-06-15Voigt Michel J.Officer, CHIEF HUMAN RESOGift65—
2026-06-05Lloyd Brian G.Officer, CHIEF LEGAL OFFIGift2.00K—
2026-05-20Gunderson Thomas J.DirectorOption exercise13.75K$717.34K
2026-05-20Gunderson Thomas J.DirectorOption exercise7.50K$391.27K
2026-05-18Ward Lynne N.DirectorGrant3.46K—
2026-05-18Ward Scott R.DirectorGrant3.46K—
2026-05-18Gunderson Thomas J.DirectorGrant3.46K—
2026-05-18Evans Stephen C.DirectorGrant3.46K—
2026-05-18Kaiser Laura S.DirectorGrant3.46K—

Flow & Concentration

Insider 180d net-$1.82M
Insider buys / sells0 / 1
Insider biasNeutral
13F holders0
Top-5 share0.0%
HHI0 (—)

SEC Filings

DateFormDoc
2026-08-054view
2026-07-308-Kview
2026-07-3010-Qview
2026-06-2611-Kview
2026-06-174view
2026-06-084view
2026-05-214view
2026-05-194view
2026-05-194view
2026-05-194view
2026-05-194view
2026-05-194view
2026-05-194view
2026-05-194view
2026-05-194view

The Long Run

FY 2011–2025 · 15 years

LineLatestCAGRTrend
Revenue$1.52B+10.8%
Gross profit$583.87M+20.6%
Operating income$184.72M+20.0%
Net income$128.49M+23.3%
Cash from ops$220.80M+15.3%

Indices

S&P SmallCap 600

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$87.25$87.95$86.77$87.50354.00K
Sep 24$87.18$87.56$86.45$87.30743.30K
Sep 23$86.96$88.14$86.93$87.07611.20K
Sep 22$86.03$87.79$85.47$87.26682.80K
Sep 21$85.88$86.23$84.99$85.49379.90K

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →